Literature DB >> 28109578

Liver fibrogenesis marker, 7S domain of collagen type IV in patients with acutely decompensated heart failure: Correlates, prognostic value and time course.

Kazuya Nagao1, Akinori Tamura2, Takeshi Morimoto3, Kiyotaka Shimamura2, Hiroshi Yukawa2, Haruyasu Ito2, Fujio Hayashi2, Toshinori Makita2, Genzou Takemura4, Yukihito Sato5, Tsukasa Inada2, Takeshi Kimura6, Masaru Tanaka2.   

Abstract

BACKGROUND: Congestion in heart failure (HF) induces multiple organ injury, which may cause remodeling of extracellular matrix. We hypothesized that liver fibrogenesis marker, 7S domain of collagen type IV (P4NP 7S) was correlated with congestion and liver injury in HF. METHODS AND
RESULTS: We measured serum P4NP 7S in two cohorts. Cohort 1 included 70 patients undergoing catheterization. P4NP 7S was correlated with pulmonary capillary wedge pressure, right ventricular and atrial pressure (r=0.50, P<0.001, r=0.42, P<0.001, r=0.39, P=0.001, respectively) but not with cardiac index (r=-0.05. P=0.7). Cohort 2 included 145 patients with acute HF, in whom we serially measured P4NP 7S at admission, discharge, early (1-month) and late (6-month) post-discharge period. γ-Glutamyltransferase and B-type natriuretic peptide were independently correlated with P4NP 7S at discharge. The cumulative 1-year incidence of death or HF hospitalization was much higher in the 3rd tertile of P4NP 7S than in the 1st and 2nd tertiles (50%, 25%, and 24%, Log-rank P=0.004). P4NP 7S enhanced risk classification when added to conventional risk factors (net reclassification improvement=0.47, P=0.02). In patients without early readmission, P4NP 7S decreased during hospitalization and remained low for up to 6months, whereas in patients with early readmission, P4NP 7S was persistently elevated during hospitalization, further increased at second admission, and remained high at 6months.
CONCLUSION: P4NP 7S was correlated with hemodynamics. The results shed new light on the pathophysiology of HF.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Collagen type IV; Congestion; Heart failure

Mesh:

Substances:

Year:  2017        PMID: 28109578     DOI: 10.1016/j.ijcard.2017.01.089

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

1.  Increased serum Wisteria floribunda agglutinin positive Mac-2 binding protein (Mac-2 binding protein glycosylation isomer) in chronic heart failure: a pilot study.

Authors:  Atsushi Okada; Hideaki Kanzaki; Yasuhiro Hamatani; Seiji Takashio; Hiroyuki Takahama; Makoto Amaki; Takuya Hasegawa; Yasuo Sugano; Satoshi Yasuda; Toshihisa Anzai
Journal:  Heart Vessels       Date:  2017-11-02       Impact factor: 2.037

2.  Selective abdominal venous congestion induces adverse renal and hepatic morphological and functional alterations despite a preserved cardiac function.

Authors:  Jirka Cops; Wilfried Mullens; Frederik H Verbrugge; Quirine Swennen; Bart De Moor; Carmen Reynders; Joris Penders; Ruth Achten; Ann Driessen; Amélie Dendooven; Jean-Michel Rigo; Dominique Hansen
Journal:  Sci Rep       Date:  2018-12-10       Impact factor: 4.379

3.  Utility of collagen-derived peptides as markers of organ injury in patients with acute heart failure.

Authors:  Kazuya Nagao; Akinori Tamura; Yukihito Sato; Reo Hata; Yuichi Kawase; Kazushige Kadota; Takahiro Horie; Naoya Sowa; Masataka Nishiga; Koh Ono; Tsukasa Inada; Masaru Tanaka
Journal:  Open Heart       Date:  2020-04-05

Review 4.  Liver abnormalities in pulmonary arterial hypertension.

Authors:  Nils P Nickel; Gian M Galura; Marc J Zuckerman; M Nawar Hakim; Haider Alkhateeb; Debabrata Mukherjee; Eric D Austin; Gustavo A Heresi
Journal:  Pulm Circ       Date:  2021-10-21       Impact factor: 3.017

5.  Liver fibrosis score predicts mortality in heart failure patients with preserved ejection fraction.

Authors:  Akiomi Yoshihisa; Yu Sato; Tetsuro Yokokawa; Takamasa Sato; Satoshi Suzuki; Masayoshi Oikawa; Atsushi Kobayashi; Takayoshi Yamaki; Hiroyuki Kunii; Kazuhiko Nakazato; Shu-Ichi Saitoh; Yasuchika Takeishi
Journal:  ESC Heart Fail       Date:  2017-10-02

6.  Circulating markers of collagen types I, III, and IV in patients with dilated cardiomyopathy: relationships with myocardial collagen expression.

Authors:  Kazuya Nagao; Tsukasa Inada; Akinori Tamura; Kenji Kajitani; Kiyotaka Shimamura; Hiroshi Yukawa; Kenji Aida; Naoya Sowa; Masataka Nishiga; Takahiro Horie; Toshinori Makita; Koh Ono; Masaru Tanaka
Journal:  ESC Heart Fail       Date:  2018-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.